Pedro Ramirez

Pedro RamirezProfessor of Gynecologic Oncology & Reproductive Medicine at MD Anderson Cancer Center

Dr. Pedro T. Ramirez is a Professor in the Department of Gynecologic Oncology & Reproductive Medicine at MD Anderson Cancer Center in Houston, Texas, USA.

He is the David M. Gershenson Distinguished Professor in Ovarian Cancer Research and Director of Minimally Invasive Surgical Research & Education. He is also the Chair of the Gynecologic Oncology Enhanced Recovery After Surgery (ERAS) Program.

In addition, he is the Editor-in-Chief of the International Journal of Gynecological Cancer. He is also the Chair of the Global Gynecologic Oncology Consortium (G-GOC) for the Gynecologic Oncology Intergroup (GCIG). The G-GOC is a collaborative consortium that conducts multi-institutional prospective trials with other sites worldwide.

Dr. Ramirez is also the Principal Investigator of the LACC Trial, a prospective randomized trial evaluating the role of minimally invasive surgery in patients with early-stage cervical cancer undergoing radical hysterectomy. The manuscript for oncologic outcomes for this study has been published in the New England Journal of Medicine. In addition, subsequent secondary analysis of the LACC Trial evaluating adverse events and quality of life in patients undergoing minimally invasive vs. open radical hysterectomy have been recently published in the American Journal of Obstetrics and Gynecology and the Lancet Oncology.

Dr. Ramirez has also written a textbook titled Principles of Gynecologic Oncology Surgery. This textbook addresses strategies of preoperative evaluation of patients undergoing gynecologic surgery, techniques and details of such procedures, and prevention and management of postoperative complications. He has also published a total of 262 articles in peer-reviewed journals and 19 book chapters. He also serves as Reviewer for 31 peer-reviewed journals. He is the recipient of multiple distinguished awards including the David M. Gershenson, MD Distinguished Professorship for Ovarian Cancer Research Endowment and, in addition, he received the 2018 Jack and Beverly Randall Prize for Excellence in Cancer Treatment at MD Anderson Cancer Center.

He is currently working on developing the North America IDEAL Network and will also be taking part in the IDEAL Robotic Surgery Colloquium in 2021. He joined the IDEAL Council in 2021.